Drug Design: Metrology and Quality Control

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".

Deadline for manuscript submissions: closed (30 October 2023) | Viewed by 196

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, 6 Miklukho-Maklaya Street, 117198 Moscow, Russia
Interests: mechanisms of biological activity of xenobiotics; pharmacokinetics; quality control of APIs and excipients

E-Mail Website
Guest Editor
Department of Pharmaceutical and Toxicological Chemistry Institute of Medicine, RUDN University, 6 Miklukho-Maklaya St, 117198 Moscow, Russia
Interests: drug design; pharmacokinetics; quality control

Special Issue Information

Dear Colleagues,

We are pleased to invite you to publish your scientific articles in a Special Issue of the journal Pharmaceutics entitled "Drug Design: Metrology and Quality Control".

The implementation of the "Quality by Design" concept includes the use of new interdisciplinary approaches to predict the pharmacological and physico-chemical properties of active pharmaceutical ingredients (APIs) and quality control of medicines.

The Special Issue "Drug Design: Metrology and Quality Control" is aimed at quality assurance in the development of new synthetic active pharmaceutical ingredients (APIs) and biologically active components of natural materials.   This Special Issue welcomes original scientific papers and reviews. Research areas may include (but are not limited to) the following: chemometric processing of the results of multivariate drug analysis, for example, the analysis of principal components (PCA) for the authentication of herbal medicines and medicinal plant materials as multicomponent samples in the absence of chemical reference substances (RMs); QSAR investigations, for example, the correlations between the "topological index - lipophilicity" and "topological index - activation energy of cell culture death (Arrhenius kinetics)/LD50 of mammals"; the use of a mathematical model with topological indices for processing two-dimensional light scattering patterns of aqueous solutions, crystalline, amorphous and liquid substances, including the identification of optical antipodes and racemate; the prediction of ligand–receptor interactions (docking); zeta potential kinetics as an indicator of the stability of biologically active nanoparticles in liquid dosage forms, including vaccines and antibodies, etc.

We look forward to receiving your submissions.

Dr. Tatiana V. Pleteneva
Dr. Olga V. Levitskaya
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • drug design
  • metrology
  • quality control

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop